BioCentury
ARTICLE | Company News

Astellas, Cyclenium Pharma deal

June 15, 2015 7:00 AM UTC

Astellas and Cyclenium partnered to identify macrocyclic compounds against undisclosed targets selected by Astellas. Cyclenium will be responsible for medicinal chemistry, including hit validation and...